Reddit Posts
10 APRIL 2026 , WHAT ARE THE BIGGEST WINNERS PRE-MARKET ?
OGN, the most undervalued Pharma, bouncing back
YOLO for Organon- Women's health company under siege
Birth control-related pharma plays $OGN $ABBV $TEVA $JNJ
Birth Control-related Pharma Plays $OGN $ABBV $TEVA $JNJ
Mentions
Got OGN shares from the Merck spin off.. should of sold it when it happened
Sun Pharmaceutical Industries (SUN.NS), opens new tab will buy U.S. drugmaker Organon & Co (OGN.N), opens new tab in an all-cash deal valued at about $11.75 billion including debt, for the largest overseas acquisition by an Indian pharmaceutical company. The move comes as Sun, India's biggest drugmaker by market value, steps up a push into higher-margin specialty medicines with a sharper focus on areas such as dermatology, oncology and obesity to offset declining U.S. sales.
I'll be simping for these OGN $2.5 Puts. OGN is down 61% in the past 5 years and these puts are dirt cheap, and such an obvious play :/ I paid $270 for 60 contracts. https://preview.redd.it/x2wcxvo7arxg1.png?width=1428&format=png&auto=webp&s=d50c46e21f59ce578e391409306f060e7dbeeb4c
need the automod Zaddy to bless my soul with the "Quantum Queen" flair :/ Also... I'll be simping for these OGN Puts. OGN is down 61% in the past 5 years and these puts are dirt cheap, and such an obvious play :/ I paid $270 for 60 contracts. https://preview.redd.it/8o9g7fp49rxg1.png?width=1428&format=png&auto=webp&s=3201789bc5f72c56f9d5bfa3c4c2ba4114150add
Just loaded up on these OGN longdated puts. The stock is down 61% in the past 5 years. They're probably NOT gonna turn this around in the next 2 years :/ either way, I paid $270 for these calls. https://preview.redd.it/xkwav2977rxg1.png?width=1433&format=png&auto=webp&s=3bb851e021296b3fbcde4a92adcef97091bf62f9
OGN agrees to deal to be acquired for $14 a share, nice
someone getting rich on OGN offer shenanigans.
OGN https://stocks.apple.com/ANTtLclPaTJSqw-d6wqsUlQ
Somebody is making out like bandits on thus OGN takeover. All the directors loaded up last week too. It was ridiculously pushed down but this is a bit sus.
OGN calls to the moon bois
I’m drawn to CVA’s valuation and high yield, but its giving me flashbacks to KHC in 2019— an experience that didn't end well for me. KHC still hasn't figured out how to revive its revenue, and defending against private labels feels like a never-ending treadmill for these legacy brands. On the other hand, GIS' pet food division has an edge against private label. I know pet owners that will spend up which creates the kind of brand loyalty and pricing power that pantry staples just don't have. That said, if CVA actually executes its turnaround, the potential upside is significantly higher. No position currently, I'm considering OGN more than anything, thanks for that!
Go ahead and buy any of these stocks with p/e high of 10.1 and low of 3.8 if you stumbled on the secret sauce: CAG, TPH, MTH, CCS, DFH, CIVI, or OGN.
Get into OGN while you can
Can we pump Organon (OGN) up?
OGN got absolutely crucified a few weeks ago for pulling forward sales to make targets. Yet that shit (and far worse) is standard practice in big tech and no one cares. Sign of very unhealthy market.
I spent some time on small cap biotech in early 2025 and concluded financial disclosures alone aren't enough to buy. Most have no earnings and are just looking for the next hot drug. It seems like you need to know their patent application pipeline - which is a lot of work and still very difficult to make value calls on unless you also have some idea of the patent universe for that class of chemicals. (Ph.D. in the space with a J.D. btw) Did buy a couple closer to mid caps - OGN (fortunately exited in early Oct but still see a value story) and VTRS. Also like the larger caps like AMGN and ABBV.
u/mkorin1 Keen to know what's your take on OGN considering their recent CEO debacle. Stock is languishing at All Time Low. I am on the fence and haven't started a position yet. What was holding me back was the Tariff overheads. But the 20% drop yesterday looks enticing !!
For OGN. I just 12.50 calls 6/18/26. Earnings is ending the month. They are a spin off, and had a huge decline. Should jam. Got stock too. For Apld I had done calls for next week at 28 a few days ago and just sold this and my 32 which were for next March.
I crushed calls and sold today for 200%. Next is OGN.
Everybody missing the OGN recovery. Crazy oversold. PE of 3.8. Just got a new drug approval from the FDA.
I've said it a couple times, and I'll say it gain. You are all missing the OGN recovery.
You are all missing the OGN recovery, and it shows.
Everyone is gunna miss OGN as it rockets back from being so undervalued.
I added some OGN (8.5) and GIBO (.0495). Looked like nice dips. Did I error?
Look at OGN. This or next quarter they could recover.
Organon for me ( OGN). They cut the dividend completely despite a 3 PE, a holes 🤮
Didn’t catch this knife but I sure have before, as recently as last month with Organon (OGN) . Best thing to do is rip the band aid off and forget about it, especially if it was about serious bad news ( dividend suspension, CEO quits). This has all the looks of a restatement to me.
I posted these in the lounge from last night, so for more info can check my history, but I'm watching the following today: PRPL, AGH, WRD Less interested possibilities CNEY, EVGO, BTOG Long plays UROY, OGN
These aren't as convincing as the ones I posted a moment ago, but just in case they run and someone has the money to put in a lot of tickers. Who knows, penny stocks be wildin. **EVGO** I doubt the stellar earnings are completely priced in, but it is probable. These guys spend a ton on lobbying successfully. **OGN** I believe this is still oversold after the dividend cut as it is currently trading at 1X EBITDA. Insiders just bought $300,000 and $100,000 in shares to prove a point, still 81% institutional ownership, and the fundamentals are great outside of 2028 debt, which the dividend cut will handle. Long-term watch. In the short term, it may continue to climb another 5-10% as I don't think the recovery is finished just yet. Will keep an eye on it. **CNEY** this could dip in the morning and possibly rebound, but I urge caution as they are coming up on their 180-day delist extension 05/27.
I would have taken that bet with you, I did something even stupider buying Organon ( OGN) before earnings for a dividend they then suspended 90% of 🤬. Not even a flyer PE of 3 with no growth
Bet I'm the only OGN holder in wsb
My last sales were in October 2024. Losses included EW, OGN, VZ. They’ve underperformed expectations and I had some capital gains to offset.
TPB. Nicotine pouches with no cigarette hangover. Growing at 15% yoy for over a decade. OGN. Pharma company rebuilding its pipeline with $1b a year in free cash flow. $12B EV with 4B market cap.
Should we invest in companies that sell IUDs? Now that Trump is president, many women are concerned about getting pregnant. IUDs are becoming a popular choice since they’re one of the most affective and long lasting birth control plans. Many have booked appointments for an IUD. Oh, Nexplanon too since that’s also effective and long lasting. But not as popular as an IUD l guess. The Cooper Companies lnc (COO), Bayer AG (BAYRY), and AbbVie Inc (ABBV) own their own form of IUD. Organon & Co (OGN) own the Nexplanon.
I usually buy the dip on dividend stocks if they have a bad earnings, bought a bunch of ET years ago around 4 and it pays a pretty substantial dividend for that price. OGN was another that got cut in half and I bought that up pretty quick too. Companies have bad quarters on occasion and get killed short term but usually bounce back pretty quick.
I had 1600 shares of PFE when it dropped like a rock. Now I have 2600 shares having lowered my basis when it was trading in the $25 range. But I like drug stocks and also hold ABBV, AZN, GSK, MRK, OGN, VTRS and a risky MRKR. I'm retired and like the steady income that drug stocks provide. i don't worry about the price fluctuations as I won't need to sell any of them. I get about $40k a year in dividends which is much more than I need to draw each year to live comfortably.
I hold about 20 dividend payers. Some are C, DOW, MO, OKE, PRU to name a few. My most recent adds are OGN (5.3% yield), TGNA (3.3%) and EVC (9.6%). I think all 3 of these have 50% upside in next year IMO. With OGN, I like their growth in women’s health and bio similarities. The other two will benefit hugely due to ad spending on the presidential year election cycle in the US.
Cap Losses Strategy Question... Thanks in advance for any input or thoughts. I am trustee and POA for my 96yo father and handling all his financial matters due to Alzheimers. He has a portfolio that generates almost enough to cover his expenses, and the rest is covered by me and my siblings. He has some positions with unrealized losses which is what I am seeking advice on. These are things like KHC, PFE, SHEL, WBD, OGN, etc. Knowing that all cap gains/losses are erased upon someone passing away... 1. Should I sell those positions to offset income & cap gains taxes for the remainder of his life? Or... 2. Should I keep them for the (small) dividends they bring in? Just thought I'd see what the braintrust of this group had to say. Thanks again for your time.
Yes, but paper losses exceeding -25% ($MP, $OGN, $VZ) are still annoying. I care about the company being useful more than corporate values, because the latter is impractical. There are many useful companies, but few that operate according to all of my preferences.
I’m going to ride my fucking YOLO in OGN to $24 before they raise guidance in Q2CC. This shits going to $30 before the end of the year. I told you guys about OGN when I bought 2500 shares at $11.40. I told you guys when I sold 500 of those shares at $18 and bought calls before Q1 earnings. I’m telling you now at $21.50 that I sold those calls and bought more further out of the money calls. I have 400 call options focused on Oct and Jan 25 strikes and 2000 total shares. My portfolio has gone from $30k->70k.
I looked into CVS last night thinking it looked cheap, but then I found a seeking alpha article on cvs by Edmund Ingham that broke the story out some for me. I of course confirmed the essential details as SA is garbage. The tough story in healthcare insurance right now is the Medicare negotiation that resulted in a net cut after inflation to compensation for Medicare plans at a time when expenses are really starting to rise from the mass of boomers. The government is really starting to squeeze the middlemen and profit margins. Whether that will be transient or not is the question. I’m long OGN which is more of a pharma company. It’s trading at 4-5x cash flows. The thing about an investment trading at 4x earnings is that the bar is so low for success that as long as the company has ongoing prospects, you’ll do fine. I did a write up on value investing yesterday. I hope you don’t mind that I copied it below. $OGN Organon Q1 Double Beat breakdown Still Long 2000 shares and some calls. Still like the stock. Obviously I’m highly regarded, so do your own research. OGN reported earnings and revenues at the top end of the range of yearly guidance with 3 quarters of growth left for the year. Another plus is that the spin off costs from Merck should be De Minimus from here. If you annualize year over year growth from Q1 out to the whole year, we’re looking at 6.5B of revenue. Women’s health grew 11% y/y, and biosimilars are growing 50% y/y, so even this 4x Q1 number is somewhat conservative. Applying Managements Ebitda guidance of 31-33% for the year to 6.5B, yields an ebitda of 2080M. Management guided for interest of 520M, depreciation of $130M, and taxes of 19.5%. This would give us a free cash flow of $1280M on a company with a market cap of $5B. One of the major concerns analysts whine about is how much debt the company has. They want the debt minus cash to be less than 3.5x ebitda. Well, currently the net debt is 8139M. If we take that 2080M of Ebitda we have a net debt target of $7280. This means if the company manages to hold onto 859M +~290M for dividends, we could see a major revaluation. It trades at 4x cash flow before one time items. That’s a pretty good margin of safety. Revenues are growing. The more money they make, the more medicines they can buy to better take advantage of their fixed costs. They have a global presence already, and seem to be licensing drugs from other pharma companies to sell without having to manufacture or develop them which seems to me to be a very high margin opportunity. I expect the stock to move up in the run up to Q2. I expect that in Q2 management will raise guidance. $30 by Q4 isn’t crazy with the charts I’m looking at on finviz. Long term todays earnings are probably worth $50-75.
[finviz](https://finviz.com/quote.ashx?t=OGN&p=d) As you notice, as of December, it started going up, as it also goes to the right. I suspect that based upon fundamental analysis that the blue line is more likely to hold than the purple line. The orange line also crossed the brown line. Which is a golden cross opportunity. I think the company has a lot of operating leverage as it’s a platform for selling drugs without any of the expense of developing drugs. It’s like a pharmaceutical royalty company.
OGN down 55% since Cramer said its incredibly cheap 🗿 https://youtu.be/XoK4gFeFCgg?si=-YU_LvR3y_o5mNrP
I exhaustedly wrote this very late and now realize I failed to include my actual tickers. I thought I had copied them onto the top: It is OGN which most meets those descriptions —————- Just adding: With BBIO as an alternative. ATAI is also a very small bit. I’m making sure to actually copy them in now, as I do recognize the goof.
Wow, Organon's stock must be on sale because it's been under siege...kinda like a Game of Thrones finale. But hey, at least it's a good investment for your portfolio and for women's health...talk about a win-win. [*wink wink*] [OGN](https://marketchameleon.com/Overview/OGN/?lu=true&pap_aid=stormofnegativity&pap_cid=11111111)
Traders seem focused on negatives. Organon will speak at Piper Sandler Annual Healthcare conference next week. Maybe something good to say. Piper just lowered PT of OGN to $22 from $32, but must still be a buy off $11 current price.
Well, looks like this company's stock is going down faster than a water slide covered in lube. Maybe if they focused on creating better products instead of blaming external factors, they wouldn't be in this mess. [YOLO](https://reddit.com/r/wallstreetbets)! But seriously, good for society? More like good for losing money [Puts on OGN, always bet against regarded companies].
Right now I am bottom feeding on value stocks that pay a dividend. PFE, CAG, EVRG, GIS and OGN are a few names.
OGN ID looks promising and its very cheap. Also IMB LN is very resilient to market corrections but it pays strong dividends
OGN baby steal around 15.80
Individual stock investing is definitely the way to go if you want long term success. My current top three picks are: OGN, CWEN & ET. Great upside and solid dividend/distribution yields.
OGN was issued to MRK holders as part of a spin off. There is technically no cost basis, so the gain amount is just the current market value and the percentage field shouldn't be shown there.
Paypal, OGN, NXST and off course Tesla.
OGN is well over 10% on Binance. Last I checked, it was around 30%.
48% Apy is pretty decent. I have some of my coins staked on Binance too; MATIC, DOT, and OGN.
Seems. you have faith in your current holding and haven't sold others. Likewise, I'm not planning to sell my POLS, ERG, OGN, GEEQ, and especially MATIC anytime soon. It gives me the highest profit ever.
So you also know that it is a fucking liar,I thought I was the only one that know about this great project called OGN protocoli have been gaining massively from it
What do we say to the God of death?, Not today. The Bull is definitely coming back, no doubt but it would really be great if most projects start investing into Metaverse before then just like what OGN and other projects are doing. Metaverse might be our savior
I bought from $0.0045 and will enjoy the ride. The team is $OGN team backed by Youtube and Paypal co-founders. 🔥🔥
I asked my stockbroker about this, because I own 3M, too. 3M ($MMM) shareholders will receive shares of Neogen ($NEOG). It doesn't sound like anything has to be requested. I didn't ask him about the other details, but the stock price of other companies I've held hasn't changed much after spinoffs ($MRK & $OGN). The applicable segment of 3M is something like 2% or less of sales, as I recall.
The bulls will always win!!! Bears only takeover for a while when the bulls are set to rest. Now let the alts reign 🔥🔥 Getting ready for $OGN
Exactly how I felt when I lost everything 😁😁. But revived with $OGN
Stacking $OGN to stake more and earn more. My sole purpose
Is simply bull 😁😁. That's why I stacked $OGN to eat the bulls
Pump and dump. If one wants an actual company that is partly devoted to women's health, OGN was spun off from Merck I think in 2021.
INTC, FB, C, OGN, F, DELL, HPQ, BABA. If you want a wild card go for NIO
Back in June of 2021, Merck ($MRK) spun off Organon ($OGN). I received 1 share of Organon for every 10 shares of Merck that I owned at the time. The spinoff and public listing occurred at the same time. Merck sent out information about the spinoff in advance. There may have been cash paid out for shareholders with less than a round 10 number of shares, but I happened to own a multiple of 10 shares. There was no lockout and the $OGN shares I received have cost basis dates corresponding to when the respective lots of $MRK were purchased.
I use the same method. What stocks do you own? Mine are C, OGN, BABA, F and DELL
I'm still buying and just added some more RIDE tokens to my holdings, in addition to some more Sylo tokens, CRA, TUS, and even OGN in my portfolio. DYOR, this is definitely the market beckoning us to invest in order to achieve financial freedom via this discounted season.
PSN and OGN are 2 i've been watching and recently buying in. Thoughts?
I own OGN and NTDOY (previous comment mentioned), looks like I found the value investors in the thread.
I should maybe point out a few great value stocks in generic drugs: VTRS and OGN !!
>\*FDA Accepts Samsung Bioepis' And Organon's SBLA For Their Citrate-Free, High-Concentration HUMIRA(R) (Adalimumab) Biosimilar Candidate $OGN ^\*Walter ^Bloomberg ^[@DeItaone](http://twitter.com/DeItaone) ^at ^2022-01-05 ^06:30:16 ^EST-0500
If you like OGN why not check out VTRS as well ? Both recently spin off companies with good earnings trying to pay off huge loads of debt on balance sheet . As long as both these companies can pay off debt while also Innovate successfully (both are aggressively laying down debt) , they would be an easy 2x return pick
I agree with other users about sticking to ETFs and high-value stocks. Something that is intrinsically worth money, and doesn't trade at a huge inflated price because of priced in future growth. If you're looking to gamble, hit the OTC or buy options. Currently I'm looking at $OGN, which trades below it's DCF and only slightly above current assets. Of the value stocks that one is my favorite. Other than that $DIS was looking attractive in the $145 range
Looks like a pretty good portfolio. You've got some value plays there, 3M, T, GE, INTC, MRK, OGN, VIAC, banks, insurance, consumer staples. Some of them are turnaround situations. High-risk value is a tough game to play, unless (or even if) you have a strong finance and accounting background and the time to apply it, a good understanding of the sectors you're looking at, and a good BS detector. I suggest you practice with what you have, deciding carefully which are worth keeping and keeping track of your analysis and results.
I thought OGN will be added but it was already added this summer.
74% mutual funds BIGRX, NASDX, TSCSX, and 8 companies that I hold stocks in are all from different sectors with the acception of MRK and OGN. Basically, it's a bunch of checks and balances but usually growing, and always recovers... So far. U want a set it and forgot? This works for me, just my 2nd year out here tho.
I’ve got stocks in ADA, OGN and MANA. Am I retarded or is this ok?